Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AbbVie signs heavily backloaded $2.1B Xilio biobucks pact in Big Pharma's latest T-cell engager deal
Fierce Biotech
Wednesday, February 12, 2025 - 10:05am
tags:
AbbVie, Xilio Therapeutics, T-cell engager
How Trump’s trade fight could impact the medtech industry
Medtech Dive
Wednesday, February 12, 2025 - 10:04am
tags:
tariffs, Medtech, devices, device manufacturing, Donald Trump
Biogen enlists Royalty for pursuit of lupus crown, securing $250M to fund phase 3 program
Fierce Biotech
Wednesday, February 12, 2025 - 10:03am
tags:
Biogen, Royalty Pharma, lupus, litifilimab
The kids are alright: How pharma can make inroads with Gen Z
Pharma Voice
Wednesday, February 12, 2025 - 10:01am
tags:
reputation, pharma industry, Gen Z, pharma marketing
Spinogenix reports top line outcomes from trial of therapy for Fragile X syndrome
Clinical Trials Arena
Wednesday, February 12, 2025 - 10:00am
tags:
Spinogenix, SPG601, Fragile X syndrome, clinical trials
Abcuro raises $200m to take muscle disease drug to market
Pharmaphorum
Wednesday, February 12, 2025 - 9:34am
tags:
Abcuro, ulviprubart, inclusion body myositis, funding
GSK plans to move vaccine R&D center from Rockville, Maryland, to the Boston area
Fierce Biotech
Wednesday, February 12, 2025 - 9:33am
tags:
GSK, vaccines, R&D, Maryland, Massachusetts
FDA approves SpringWorks' genetic disorder drug
Marketscreener
Tuesday, February 11, 2025 - 10:00pm
tags:
SpringWorks Therapeutics, FDA, neurofibromatosis, Gomekli
Vertex lays out plan to increase access and launch non-opioid pain reliever Journavx
Fierce Pharma
Tuesday, February 11, 2025 - 9:54pm
tags:
Vertex, non-opioid pain treatments, Journavx
Gilead Sciences Beats Q4 EPS Forecast
Motley Fool
Tuesday, February 11, 2025 - 9:51pm
tags:
Gilead Sciences, earnings
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
Investors Business Daily
Tuesday, February 11, 2025 - 9:50pm
tags:
Biohaven, FDA, spinocerebellar ataxia, troriluzole
Judge orders restoration of federal health websites
NPR
Tuesday, February 11, 2025 - 9:45pm
tags:
Donald Trump, Public Health, CDC, HHS, FDA
Eisai execs flag Leqembi 'expansion phase' on the horizon as Alzheimer's med grows slowlym
Fierce Pharma
Tuesday, February 11, 2025 - 9:41pm
tags:
Eisai, Leqembi, Alzheimer's disease
Flu Activity In US Now May Be Highest Since 2017-2018
Forbes
Tuesday, February 11, 2025 - 9:37pm
tags:
Flu
Trump’s tariffs will trickle down the clinical trial chain
Clinical Trials Arena
Tuesday, February 11, 2025 - 9:34pm
tags:
tariffs, Donald Trump, clinical trials, China
Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Fierce Biotech
Tuesday, February 11, 2025 - 11:42am
tags:
Novartis, abelacimab, Anthos Therapeutics, M&A, spinoffs
Leaked Conference Article Shows Pfizer’s Positive Phase I Prostate Cancer Data
BioSpace
Tuesday, February 11, 2025 - 11:41am
tags:
Pfizer, ASCO, Mevrometostat, prostate cancer
Tariffs raise concern among generic drugmakers, as advocacy groups seek exemptions
BioPharma Dive
Tuesday, February 11, 2025 - 11:29am
tags:
tariffs, China, Canada, Mexico, Donald Trump, generics
Incyte exits immuno-oncology pact, leaving Agenus weighing options for assets
Fierce Biotech
Tuesday, February 11, 2025 - 11:28am
tags:
Incyte, immuno-oncology, Agenus
AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment
Pharmaceutical Business Review
Tuesday, February 11, 2025 - 11:27am
tags:
radiopharmaceuticals, Eli Lilly, AdvanCell, cancer, alpha radiation

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.